Navigation Links
Talyst Receives Multiple Honors for Workplace Excellence
Date:7/9/2009

Company Recognized for Exceptional Benefits, Work and Life Equilibrium and Leadership Culture

Bellevue, WA (PRWEB) July 9, 2009 -- Talyst, a leader in pharmacy automation systems, found June to be an award-filled month as it received kudos for cultivating an excellent work environment. Talyst was awarded as one of "Washington's 100 Best Companies to Work For 2009" by Seattle Business Monthly, and is a finalist for the Puget Sound Business Journal's "Washington's Best Workplaces."

Talyst is a relatively small company with just over 100 employees, but its products play a crucial role in health care facilities. Talyst provides automated medication management hardware and software to acute care hospital pharmacies, long-term care facilities and correctional facilities nationwide. With Talyst's products, the right medications go to the right patient at the right time and in the right dose. It is fast-paced and demanding work, but Talyst's employees meet that challenge.

"Our employees are the lifeblood of our company, and we work hard to provide them with a productive, positive and fun work environment," said Carla Corkern, Talyst CEO and chairman of the board. "Most rewarding for all of us, however, is knowing the profound impact our work has on both improving safety outcomes for patients in health care facilities and diminishing the waste footprints generated by traditional medication dispensing methods."

Talyst has been recognized by both awards for providing excellent benefits, work/life balance and an exceptional leadership culture. Talyst earned these honors by offering flexible schedules to ensure that employees' family is never neglected; scheduling quarterly All-Hands Meetings to deliver honest fiscal outlooks, share smart
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
2. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
3. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
4. Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
5. Americas #1 Companion Gets Respect: The CATalyst 2009 Top 10 Cat-Friendly Cities
6. Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction
7. The Catalyst Foundations Groundbreaking ACE Study-Based Services Bring Transformational Change to Healthcare
8. Upcoming Packard/Stanford Autism Symposium a Catalyst for Collaboration among Researchers and Community
9. Talyst Moves Patient Safety and Inventory Control Beyond the Hospital
10. Talyst Unveils InSite for Long-Term Care
11. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 1Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 1Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 3Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 4